Inhibition of monocyte/macrophage metabolic reprogramming with 2-DG (2-deoxyglucose) in vivo reduces cardiac [1-13C]lactate signal and IL-1β levels post-MI, providing proof of concept of magnetic resonance-visible immunomodulation. The gene discussed is IL1B; the disease is myocardial infarction.